A Prospective, Open Label, Treatment Use Study of Patient Safety Following Transfusion of INTERCEPT Platelet Components

Clinical trial NCT02305732 · COMPLETED

Trial details

NCT number: NCT02305732
Sponsor: Cerus Corporation
Status: COMPLETED
Study type: OBSERVATIONAL

Chikungunya Virus Dengue Virus

Start date: 2015-03-01
Primary completion: 2016-05-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.